Nivalis Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.nivalis.com
Safety and Tolerability Study of N6022 in Healthy Subjects
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Nivalis Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT01147406
- Locations
- 🇺🇸
Parexel Early Phase Unit, Baltimore, Maryland, United States
© Copyright 2024. All Rights Reserved by MedPath